Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 4
Submit an article Journal homepage
1,708
Views
31
CrossRef citations to date
0
Altmetric
Author's View

Immune checkpoints

A therapeutic target in triple negative breast cancer

Akhil Chawla Department of Surgical Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Anne V Philips Department of Surgical Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA
,
Gheath Alatrash Department of Stem Cell Transplant and Cellular Therapy; The University of Texas MD Anderson Cancer Center; Houston, TX USA
&
Elizabeth Mittendorf Department of Surgical Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USACorrespondence[email protected]
Article: e28325 | Received 15 Feb 2014, Accepted 21 Feb 2014, Published online: 08 Apr 2014

References

  • Couzin-Frankel J. Breakthrough of the year 2013. Cancer immunotherapy. Science 2013; 342:1432 - 3; http://dx.doi.org/10.1126/science.342.6165.1432; PMID: 24357284
  • Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995; 182:459 - 65; http://dx.doi.org/10.1084/jem.182.2.459; PMID: 7543139
  • Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711 - 23; http://dx.doi.org/10.1056/NEJMoa1003466; PMID: 20525992
  • Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992; 11:3887 - 95; PMID: 1396582
  • Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012; 366:2455 - 65; http://dx.doi.org/10.1056/NEJMoa1200694; PMID: 22658128
  • Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366:2443 - 54; http://dx.doi.org/10.1056/NEJMoa1200690; PMID: 22658127
  • Grosso J, Horak CE, Inzunza D, Cardona DM, Simon JS, Gupta AK, Sankar V, Park J, Kollia G, Taube JM, et al. Association of tumor PD-L1 expression and immune biomarkers with clinical activity in patients with advanced solid tumors treated with nivolumab (anti-PD-1; BMS-936558; ONO-4538). J Clin Oncol 2013 ; (Supplement) 31:3016
  • Mittendorf EA, Philips AV, Meric-Bernstam F, Qiao N, Wu Y, Harrington SM, Su X, Wang Y, Gonzalez-Angulo AM, Akcakanat A, et al. PD-L1 Expression in Triple Negative Breast Cancer. Cancer Immunol Res 2014; Forthcoming http://dx.doi.org/10.1158/2326-6066.CIR-13-0127
  • Vreeland TJ, Clifton G, Hale DF, Sears AK, Patil R, Holmes JP, Ponniah S, Mittendorf EA, Peoples GE. Final Results of the Phase I/II Trials of the E75 Adjuvant Breast Cancer Vaccine. Cancer Res 2012; (Supplement 3) 72:P5-16-02
  • Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004; 10:909 - 15; http://dx.doi.org/10.1038/nm1100; PMID: 15340416

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.